Cytotoxic Granzyme C-expressing ILC1s Contribute to Antitumor Immunity and Neonatal Autoimmunity

Overview

Journal Sci Immunol

Specialty Allergy & Immunology

Date 2022 Apr 8

PMID 35394814

Authors

Briana G Nixon

Chun Chou

Chirag Krishna

Saida Dadi

Adam O Michel

Andrew E Cornish

Emily R Kansler

Mytrang H Do

Xinxin Wang

Kristelle J Capistrano

Alexander Y Rudensky

Christina S Leslie

Ming O Li

Affiliations

Soon will be listed here.

Abstract

Innate lymphocytes are integral components of the cellular immune system that can coordinate host defense against a multitude of challenges and trigger immunopathology when dysregulated. Natural killer (NK) cells and innate lymphoid cells (ILCs) are innate immune effectors postulated to functionally mirror conventional cytotoxic T lymphocytes and helper T cells, respectively. Here, we showed that the cytolytic molecule granzyme C was expressed in cells with the phenotype of type 1 ILCs (ILC1s) in mouse liver and salivary gland. Cell fate-mapping and transfer studies revealed that granzyme C-expressing innate lymphocytes could be derived from ILC progenitors and did not interconvert with NK cells, ILC2s, or ILC3s. Granzyme C defined a maturation state of ILC1s. These granzyme C-expressing ILC1s required the transcription factors T-bet and, to a lesser extent, Eomes and support from transforming growth factor-β (TGF-β) signaling for their maintenance in the salivary gland. In a transgenic mouse breast cancer model, depleting ILC1s caused accelerated tumor growth. ILC1s gained granzyme C expression following interleukin-15 (IL-15) stimulation, which enabled perforin-mediated cytotoxicity. Constitutive activation of STAT5, a transcription factor regulated by IL-15, in granzyme C-expressing ILC1s triggered lethal perforin-dependent autoimmunity in neonatal mice. Thus, granzyme C marks a cytotoxic effector state of ILC1s, broadening their function beyond "helper-like" lymphocytes.

Citing Articles

Autocrine TGF-β1 drives tissue-specific differentiation and function of resident NK cells.

Sparano C, Solis-Sayago D, Zangger N, Rindlisbacher L, Van Hove H, Vermeer M J Exp Med. 2024; 222(3).

PMID: 39692745 PMC: 11654236. DOI: 10.1084/jem.20240930.

GPR34 is a metabolic immune checkpoint for ILC1-mediated antitumor immunity.

Yan J, Zhang C, Xu Y, Huang Z, Ye Q, Qian X Nat Immunol. 2024; 25(11):2057-2067.

PMID: 39358444 DOI: 10.1038/s41590-024-01973-z.

Bridging Chronic Inflammation and Digestive Cancer: The Critical Role of Innate Lymphoid Cells in Tumor Microenvironments.

Shen G, Wang Q, Li Z, Xie J, Han X, Wei Z Int J Biol Sci. 2024; 20(12):4799-4818.

PMID: 39309440 PMC: 11414386. DOI: 10.7150/ijbs.96338.

Fasting reshapes tissue-specific niches to improve NK cell-mediated anti-tumor immunity.

Delconte R, Owyong M, Santosa E, Srpan K, Sheppard S, McGuire T Immunity. 2024; 57(8):1923-1938.e7.

PMID: 38878769 PMC: 11684419. DOI: 10.1016/j.immuni.2024.05.021.

Distinct developmental pathways generate functionally distinct populations of natural killer cells.

Ding Y, Lavaert M, Grassmann S, Band V, Chi L, Das A Nat Immunol. 2024; 25(7):1183-1192.

PMID: 38872000 DOI: 10.1038/s41590-024-01865-2.

References

Bernink J, Krabbendam L, Germar K, de Jong E, Gronke K, Kofoed-Nielsen M . Interleukin-12 and -23 Control Plasticity of CD127(+) Group 1 and Group 3 Innate Lymphoid Cells in the Intestinal Lamina Propria. Immunity. 2015; 43(1):146-60. DOI: 10.1016/j.immuni.2015.06.019. View

Bando J, Liang H, Locksley R . Identification and distribution of developing innate lymphoid cells in the fetal mouse intestine. Nat Immunol. 2014; 16(2):153-60. PMC: 4297560. DOI: 10.1038/ni.3057. View

Crinier A, Milpied P, Escaliere B, Piperoglou C, Galluso J, Balsamo A . High-Dimensional Single-Cell Analysis Identifies Organ-Specific Signatures and Conserved NK Cell Subsets in Humans and Mice. Immunity. 2018; 49(5):971-986.e5. PMC: 6269138. DOI: 10.1016/j.immuni.2018.09.009. View

Krabbendam L, Bernink J, Spits H . Innate lymphoid cells: from helper to killer. Curr Opin Immunol. 2020; 68:28-33. DOI: 10.1016/j.coi.2020.08.007. View

Fan X, Rudensky A . Hallmarks of Tissue-Resident Lymphocytes. Cell. 2016; 164(6):1198-1211. PMC: 4973889. DOI: 10.1016/j.cell.2016.02.048. View

Yu Y, Tsang J, Wang C, Clare S, Wang J, Chen X . Single-cell RNA-seq identifies a PD-1 ILC progenitor and defines its development pathway. Nature. 2016; 539(7627):102-106. DOI: 10.1038/nature20105. View

Sojka D, Plougastel-Douglas B, Yang L, Pak-Wittel M, Artyomov M, Ivanova Y . Tissue-resident natural killer (NK) cells are cell lineages distinct from thymic and conventional splenic NK cells. Elife. 2014; 3:e01659. PMC: 3975579. DOI: 10.7554/eLife.01659. View

Schneider C, Lee J, Koga S, Ricardo-Gonzalez R, Nussbaum J, Smith L . Tissue-Resident Group 2 Innate Lymphoid Cells Differentiate by Layered Ontogeny and In Situ Perinatal Priming. Immunity. 2019; 50(6):1425-1438.e5. PMC: 6645687. DOI: 10.1016/j.immuni.2019.04.019. View

Melsen J, Lugthart G, Lankester A, Schilham M . Human Circulating and Tissue-Resident CD56(bright) Natural Killer Cell Populations. Front Immunol. 2016; 7:262. PMC: 4927633. DOI: 10.3389/fimmu.2016.00262. View

10.

Walzer T, Chiossone L, Chaix J, Calver A, Carozzo C, Garrigue-Antar L . Natural killer cell trafficking in vivo requires a dedicated sphingosine 1-phosphate receptor. Nat Immunol. 2007; 8(12):1337-44. DOI: 10.1038/ni1523. View

11.

Spits H, Bernink J, Lanier L . NK cells and type 1 innate lymphoid cells: partners in host defense. Nat Immunol. 2016; 17(7):758-64. DOI: 10.1038/ni.3482. View

12.

Friedrich C, Taggenbrock R, Doucet-Ladeveze R, Golda G, Moenius R, Arampatzi P . Effector differentiation downstream of lineage commitment in ILC1s is driven by Hobit across tissues. Nat Immunol. 2021; 22(10):1256-1267. PMC: 7611762. DOI: 10.1038/s41590-021-01013-0. View

13.

Franklin R, Liao W, Sarkar A, Kim M, Bivona M, Liu K . The cellular and molecular origin of tumor-associated macrophages. Science. 2014; 344(6186):921-5. PMC: 4204732. DOI: 10.1126/science.1252510. View

14.

Dadi S, Chhangawala S, Whitlock B, Franklin R, Luo C, Oh S . Cancer Immunosurveillance by Tissue-Resident Innate Lymphoid Cells and Innate-like T Cells. Cell. 2016; 164(3):365-77. PMC: 4733424. DOI: 10.1016/j.cell.2016.01.002. View

15.

Yomogida K, Bigley T, Trsan T, Gilfillan S, Cella M, Yokoyama W . Hobit confers tissue-dependent programs to type 1 innate lymphoid cells. Proc Natl Acad Sci U S A. 2021; 118(50). PMC: 8685927. DOI: 10.1073/pnas.2117965118. View

16.

Xu W, Cherrier D, Chea S, Vosshenrich C, Serafini N, Petit M . An Id2-Reporter Mouse Redefines Innate Lymphoid Cell Precursor Potentials. Immunity. 2019; 50(4):1054-1068.e3. PMC: 6477155. DOI: 10.1016/j.immuni.2019.02.022. View

17.

Constantinides M, McDonald B, Verhoef P, Bendelac A . A committed precursor to innate lymphoid cells. Nature. 2014; 508(7496):397-401. PMC: 4003507. DOI: 10.1038/nature13047. View

18.

Vivier E, Artis D, Colonna M, Diefenbach A, Di Santo J, Eberl G . Innate Lymphoid Cells: 10 Years On. Cell. 2018; 174(5):1054-1066. DOI: 10.1016/j.cell.2018.07.017. View

19.

Tang Y, Wang D, Luo H, Xiao M, Zhou H, Liu D . Aggressive NK-cell leukemia: clinical subtypes, molecular features, and treatment outcomes. Blood Cancer J. 2017; 7(12):660. PMC: 5802497. DOI: 10.1038/s41408-017-0021-z. View

20.

Johnson H, Scorrano L, Korsmeyer S, Ley T . Cell death induced by granzyme C. Blood. 2003; 101(8):3093-101. DOI: 10.1182/blood-2002-08-2485. View